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Abstract
Urinary tract infections are the most common cause of E. coli bloodstream infections (BSI) but the mechanism of
bloodstream invasion is poorly understood. Some clinical isolates have been observed to shield themselves with
extracellular amyloid fibers called curli at physiologic temperature. We hypothesize that curli fiber assembly at 37uC
promotes bacteremic progression by urinary E. coli strains. Curli expression by cultured E. coli isolates from bacteriuric
patients in the presence and absence of bacteremia were compared using Western blotting following amyloid fiber
disruption with hexafluoroisopropanol. At 37uC, urinary isolates from bacteremic patients were more likely to express curli
than those from non-bacteremic patients [16/22 (73%) vs. 7/21 (33%); p= 0.01]. No significant difference in curli expression
was observed at 30uC [86% (19/22) vs. 76% (16/21); p= 0.5]. Isolates were clonally diverse between patients, indicating that
this phenotype is distributed across multiple lineages. Most same-patient urine and blood isolates were highly related,
consistent with direct invasion of urinary bacteria into the bloodstream. 37uC curli expression was associated with
bacteremic progression of urinary E. coli isolates in this population. These findings suggest new future diagnostic and
virulence-targeting therapeutic approaches.
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Introduction
Curli fibers are extracellular amyloid fibrils that are variably
expressed by E. coli (for review, see [1]). Characteristic of amyloids,
curli fibers are highly stable, insoluble, high molecular weight
protein complexes dominated by a beta sheet secondary structure.
While many amyloid fibers have been described for different
bacterial organisms, curli is the only known amyloid fibers
encoded by E. coli and other Enterobactericiae such as Salmonella
spp. (for review, see [2]). Unlike human amyloids, curli fibers are
deliberately assembled by dedicated bacterial machinery [3–6].
The curli fiber biogenesis requires both structural (CsgA and
CsgB) and non-structural (CsgD, CsgE, CsgF, and CsgG)
components encoded by genes on two divergent operons
[4,5,7,8]. Curli assembly follows an ordered process termed
‘‘nucleation-precipitation’’ that has been extensively studied in
many laboratories (for review, please see [1]). Curli fibers are
composed of primarily CsgA proteins with CsgB proteins as minor
components. During curli assembly, CsgB monomers are exported
outside of bacteria through CsgG pores, fold into proper
conformation, and associate with bacterial cell surface [7].
Chaperoned by CsgE proteins, CsgA monomers are also exported
in the same fashion as unfolded proteins out to the cell surfaces.
Out on bacterial surfaces, initially exported CsgA monomoers fold
into proper conformation upon interaction with CsgB and
associate with CsgB proteins, forming nucleation centers. Subse-
quent CsgA monomers exported out onto bacterial surfaces
quickly assume the proper conformation upon interaction with the
nucleation centers and are incorporated onto the growing fibers in
association with the existing CsgA proteins in the fibers. Curli
fibers have been implicated in biofilm formation on both abiotic
and biotic surfaces [9–12], persistent avian colibacillosis [13], and
immune modulation in mammalian hosts [14]. Curli fibers also
have been implicated to play a role in bladder colonization at 6
hours post-infection in an experimental UTI model in mice [9]. In
that report, deletion of csgA gene in a prototypic uropathogenic E.
coli resulted in reduced bladder colonizations at 6 hrs post-
infection. Based on these findings, curli fibers have been proposed
to be a virulence factor in human urinary tract infections (UTIs)
[15] and bacteremia [16].
Upon their discovery, curli fibers were known to be expressed at
temperatures below 26uC, leading to speculation that they are an
adaption for survival at lower temperatures [17]. Bian et al. later
demonstrated robust curli production at 37uC in a series of E. coli
blood isolates from hospitalized patients [16]. Together with a
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demonstrated serological response to curli in septic patients, this
raised the possibility that curli expression at physiologic temper-
ature is an E. coli virulence trait. Whether 37uC curli production
facilitates bacterial migration from the urinary tract into the
bloodstream or ensures survival in the bloodstream has been
unclear.
We hypothesized that curli expression by E. coli at physiologic
temperature promotes bacteremic progression during urinary tract
infections. Previous studies lacked either clear information on the
clinical severity of UTI patients [18] or a non-bacteremic
comparator group necessary to seek associations between curli
expression and bacteremic progression [16]. To test our hypoth-
esis, we compared curli expression between bacteremic and non-
bacteremic urinary E. coli isolates from a prospective cohort study
of hospitalized patients with urinary tract infection. Curli
expression by cultured isolates was assessed with an optimized
Western blot analysis. Our results revealed a strong correlation
between curli expression at 37uC and urinary-source bloodstream
infections. Genetic typing showed that curli expression among
bacteremic isolates was distributed across multiple lineages.
Materials and Methods
Clinical E. coli Isolates and Patient Data
Clinical E. coli isolates were obtained through an observational
study on risk factors for urinary-source bacteremia in patients with
E. coli bacteriuria. Urine and blood isolates (if the patient was
bacteremic) of enrolled patients were identified in the Barnes-
Jewish Hospital Medical Microbiology Laboratory using conven-
tional biochemical methods and stored in skim milk at 280uC
[19].
Curli Expression Analysis
Curli expression was identified by Western blotting of cultured
bacteria. Bacterial isolates were patched onto Luria-Bertani (LB)
plates from frozen stocks and incubated overnight at 37uC.
Subsequently, a small amount of bacteria was resuspended in
100 uL of YESCA broth (10 g/L casamino acid and 1.2 g/L yeast
extract) and streaked onto YESCA plates (YESCA broth
supplemented with 20 g/L Bacto agar) to allow for curli
expression. These plates were then incubated for 48 hours at
30uC and 37uC. For Western blotting, a 1 cm square patch of
bacteria was scraped off for each strain and resuspended in 150 mL
of phosphate buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl,
4.3 mM Na2HPO4, 1.47 mM KH2PO4). These bacteria were
pelleted by centrifugation at 14,000 rpm for 10 minutes and
resuspended in 100 mL of the curli-depolymerizing agent hexa-
fluoroisopropanol (HFIP). After 10 minutes of incubation at 23uC,
samples were dried in a Savant Speedvac vacuum concentrator
(ThermoFisher Scientific, Waltham, MA).
Dried HFIP-treated pellets were resuspended in 100 mL of 46
gel loading buffer (0.125 M Tris base, 10% 2-mercaptoethanol,
20% glycerol, 6% sodium dodecyl sulphate, 0.02% bromophenol
blue) and boiled at 95uC for 10 minutes before loading onto SDS-
PAGE gels. Ten (10) uL of each sample was loaded into the gels
along with BLUEstain 3 Protein Ladder (Gold Biotechnology, St.
Louis, MO) and electrophoresed at a constant current of 30 mAh.
After electrophoresis, gels and PVDF membranes (pre-wetted in
methanol) were equilibrated in Laemmli transfer buffer (14.4 g/L
glycine, 3.02 g/L Tris base, 10% methanol) for 15 minutes.
Western transfer of proteins onto PVDF membranes was carried
out at 30 V and 4uC overnight.
Following transfer, PVDF membranes were rinsed in TBST
(50 mM Tris, 150 mM NaCl, 0.05% Tween 20, pH 7.6) and
placed in blocking buffer (TBST, 1.5% BSA, 1.5% non-fat dry
milk) for 1 hour. Membranes were immunoblotted with rabbit
anti-CsgA antisera (Proteintech, Chicago, IL) in the blocking
buffer (1:5,000 dilution) for 1 hour. After four 5-minute TBST
wash cycles, membranes were incubated with horseradish
peroxidase (HRP)-conjugated goat-anti-rabbit secondary antibody
in the blocking buffer (1:5,000 dilution) for 1 hour. After 4 wash
cycles with TBST, the membranes were developed with Super-
Signal West Pico Chemiluminescent Substrate (Thermo Scientific,
Rockford, IL) for 5 minutes and then immediately exposed to
radiography film in the darkroom. Bacteria expressing curli fibers
produced a 15 kDa reactive band on the radiography films
corresponding to CsgA, the major structural protein of curli fibers.
Enterobacterial Repetitive Intergenic Consensus-PCR
Fingerprinting
The relatedness of bacterial isolates was assessed using
Enterobacterial Repetitive Intergenic Consensus (ERIC)-PCR in
conjunction with the DiversiLab system [20]. In brief, DNA was
extracted from isolates using the MoBio Bacteremia DNA
Isolation Kit (MoBio Laboratories, Carlsbad, CA) and ERIC-
PCR was performed using RAPD Ready-to-go analysis beads (GE
Healthcare, Pittsburg, PA) in a final reaction volume of 25 uL,
including approximately 100 ng of genomic DNA, and 125 pmol
of each primer (ERIC1: ATGTAAGCTCCTGGGGATTCAC
and ERIC 2: AAGTAAGTGACTGGGGTGAGCG). Amplifica-
tion cycling parameters included 40 cycles of: 94uC for 1 min,
54uC for 1 min and 72uC for 2 min, followed by a final extension
step of 72uC for 5 minutes. Resulting PCR products were resolved
using DiversiLab DNA chips (bioMerieux, Durham, NC) on the
Agilent 2100 system (Agilent Technologies, Santa Cara, CA). The
DiversiLab software was used to compare banding patterns and
determine the similarity of the isolates (similarity index, SI). The SI
of 85% is the standard cut-off level for related isolates of Gram-
negative bacteria in an outbreak investigation or epidemiology
purpose [21–24].
Statistical Analysis
Statistical analyses were done with the software package PRISM
(GraphPad, La Jolla CA) and with EpiInfo (CDC, Atlanta GA).
We used Chi-square test or Fisher’s exact test as appropriate to
compare rates between groups. A p value of ,0.05 was considered
statistically significant.
Ethics Statement
We obtained bacterial isolates and the corresponding clinical
information from a previously described [19] observational study
in which patients admitted to Barnes-Jewish Hospital were
enrolled. The Human Research Protection Office at Washington
University (which acts as the Institutional Review Board for
Barnes-Jewish Hospital) approved the study with a waiver of
informed consent due to its observational nature [Approval#
201105193]. All bacterial isolates and clinical information (used to
determine the severity of urinary tract infection) were de-identified
prior to the analyses presented here.
Results
Patient Isolates
To determine whether curli fiber expression is associated with
urinary-source bacteremia, we compared bacterial isolates from 22
bacteremic patients to 21 non-bacteremic urinary isolate controls
[19]. More bacteremic than non-bacteremic patients exhibited
fever [73% (16/22) vs. 48% (10/21)] or septicemia [91% (20/22)
Curli in Bacteriuric E. coli
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vs. 67% (14/21)]; however, the frequency of these clinical
symptoms between the two groups were not statistically significant
(p=0.08 and p=0.06, respectively). Pyelonephritis was more
frequent in bacteremic than in non-bacteremic patients [77% (17/
22) vs. 48% (10/21); p=0.04].
Curli Expression as a Function of Temperature and UTI
Severity
To determine whether curli expression at 37uC is associated
with bloodstream infections, we compared cultured bacteremic
and non-bacteremic urine isolates by Western blot detection of
CsgA, the major curli subunit. The percentage of curli expressors
was significantly higher in bacteremic versus non-bacteremic
isolates [73% (16/22) vs. 33% (7/21) respectively; p=0.01]
(Table 1). To assess whether this difference reflects an intrinsic
curli-deficiency (in some strains) or a specific temperature effect,
we compared curli expression between these strains at 30uC. At
30uC, curli expression frequencies were no longer different
between bacteremic versus non-bacteremic urinary isolates [86%
(19/22) vs. 76% (16/21); p=0.5]. Overall, most strains were
capable of curli expression, with a higher proportion of all urine
isolates expressing curli at 30uC [35/43 (81%)] than at 37uC [23/
43 (55%)] (p=0.01).
Genetic Diversity of Bacteremic Isolates
To determine whether curli expression reflects the idiosyncratic
property of a single clonal epidemic strain, rather than an
independent pathogenic factor, we used ERIC-PCR to evaluate
bacteremic strain relatedness (Figure 1A). For Enterobacteriaceae,
this ERIC-PCR assay is similar to PFGE in its ability to
discriminate between related isolates and to group like isolates as
similar [21,22,25]. 37uC curli-expressers were distributed across a
range of ERIC types and include multiple pairs with less than the
85% similarity cutoff often used to distinguish strains (Figure 1B).
Overall, this analysis shows that the curli expression phenotype
observed in this cohort was not attributable to a single epidemic
strain.
Relationship of Same-patient Urine and Blood Isolates
In UTI-associated bloodstream infection, the dominant urinary
E. coli strain may directly invade the bloodstream or instead
facilitate invasion by a second E. coli strain in the context of a
multi-strain infection. To address these possibilities, we deter-
mined the relatedness of same-patient blood and urinary isolates
using both ERIC-PCR and curli expression. Among the bacterial
isolate pairs from 22 patients analyzed, 16 pairs showed $95%
genetic relatedness while 5 pairs were between 90% and 95% in
genetic relatedness, which were above the standard 85% similarity
cutoff (Table 2). Only the non-curli-expressing blood and urine
isolate pair from patient #12 had a similarity index suggesting that
the two strains were not related (SI ,85%). A similarly high
degree of urine-blood pair relatedness has also been observed in a
PFGE study of a separate patient cohort [26]. For curli expression,
no significant difference was noted between blood vs. urine isolates
within bacteremic individuals at either 37uC [59% (13/22) vs.
73% (16/22); p=0.5] or 30uC [77% (17/22) vs. 86% (19/22);
p=0.7]. Altogether, these findings support, but do not prove, that
the dominant urinary isolate is most likely to become the blood
isolate in E. coli bacteremia patients. A more detailed molecular
typing effort might distinguish more unrelated pairs.
Discussion
In this study of E. coli isolates, we observed a correlation
between bacterial curli fiber expression at 37uC and secondary E.
coli bloodstream infection. ERIC-PCR typing showed that blood
E. coli isolates almost always match the corresponding urine isolate.
Curli expression was distributed across a genetically diverse group
of urine and blood strains from bacteremic patients. Together
these findings support an independent role for curli expression as a
bacteremic progression correlate in urinary E. coli isolates.
Previous studies have shown that a substantial proportion of
urinary tract [15] and bloodstream E. coli isolates [16] can express
curli fibers. Another group, Bokranz and colleagues, studied curli
fiber expression in gastrointestinal and urinary isolates at different
temperatures but did not provide information on clinical severity
in UTI patients [18]. It remained unclear from these studies
whether curli expression is associated with bacteremia or simply
reflects its association with UTI, a common source for bacteremia.
The expression difference we observed in bacteremic versus non-
bacteremic urinary E. coli isolates supports 37uC curli expression as
a marker of UTI strains with bacteremic potential, alongside kpsM
and P-related fimbrial genes [19].
Many previous studies suggested that the underlying patho-
physiologic gains-of-function are attributable to curli. Kai-Larsen
and colleagues have reported that curli and cellulose expression
was associated with increased uropathogenic E. coli virulence in
mouse UTI models [14]. Curli expression facilitated epithelial cell
adherence and increased resistance to the human antimicrobial
peptide LL-37, urinary levels of which are increased during UTI
[27]. Uropathogens may also use curli fibers to prepare an
external peptidoglycan matrix in biofilm-related infections; a study
in Shiga toxin-producing E. coli described how such a curli-
mediated biofilm protected bacteria against environmental stress
[28]. Curli’s association with some biofilm types further raise the
possibility that its expression may facilitate phenotypic resistance
to antibiotics commonly used for UTI. Although high relatedness
between the urinary and blood isolates in each patient suggests
that curli may protect expressing bacteria, the possibility remains
that a curli-expressing strain may facilitate bacteremic invasion by
an adjacent, non-expressing strain by shielding it in a biofilm or
through an immunologic effect. These or other unidentified curli-
associated properties may facilitate bacteremic progression of
Table 1. Curli fiber expression in urinary E. coli specimens from bacteremic versus non-bacteremic patients.
306C 376C
Bacteremic
Urine Isolates
Non-bacteremic Urine
Isolates (controls) p value
Bacteremic Urine
Isolates
Non-bacteremic Urine
Isolates (controls) p value
Positive 19 (86%) 16 (76%) 0.5 16 (73%) 7 (33%) 0.01
Total 22 21 22 21
doi:10.1371/journal.pone.0086009.t001
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urinary E. coli strains through increased kidney or vascular
invasion.
A notable limitation of our study was the heterogeneity of the
control group, which consisted of patients with confirmed
negative blood cultures in the setting of asymptomatic bacteri-
uria, cystitis, and pyelonephritis. The time-consuming Western
blot-based analytical approach used in this study limited the
control group sample size and remains a challenge for future
work. Specific detection of curli subunits following chemical
amyloid disruption, although time consuming and technically
tedious, remains the gold standard method for curli detection.
Because the CsgA protein comprises the vast majority of curli
fibers, it is the most sensitive and specific measure of curli fiber
formation. Agar plate colony morphology combined with an
amyloid-binding dye - most commonly Congo Red - has also
been used in published studies to detect curli expression [29–
31]. Unfortunately, Congo Red also binds to cellulose polymers
expressed by many pathogenic E. coli to give a signal in the
absence of curli expression [29,32], compromising the assay’s
specificity. We attempted to improve this assay by combining
Congo Red and Bromophenol Blue dyes (Figure S1) and
comparing the results to Western blot. Unfortunately, we were
unable to identify conditions that permitted clear visual
interpretation of results, particularly at 37uC (Figure S2). Our
findings show that Western Blot analysis, although laborious,
remains as the most specific and sensitive assay to detect 37uC
Figure 1. ERIC-PCR analysis of bacterial isolates from bacteremic patients. Isolates are labeled by patient number followed by ‘‘B’’ for blood
isolates and ‘‘U’’ for urine isolates. (A) Dendrogram analysis of bacterial isolates from bacteremic patients. Bacterial isolates from bacteremic patients
were characterized by ERIC-PCR using DiversiLab software to assess strain relatedness. Dendrogram analysis revealed marked genetic similarities
between blood and urine isolates of the same patients with clustering to the same sub-branches or nodes. However, bacterial isolates expressing
curli at 37uC (highlighted in yellow) were distributed widely across multiple ERIC groups. (B) Inter- and intra-patient isolate genetic similarity matrix. A
genetic similarity matrix based on ERIC-PCR banding patterns was generated for bacterial isolates from bacteremic patients. The data in the
dendrogram in (A) is lined up with that in the similarity matrix (B) according to the isolates. With the exception of isolates from patient 12, intra-
patient urinary and blood isolate similarities exceed 90%. Isolate similarity between patients was lower, with only a small cluster of isolates from 5
patients sharing over 95% similarity. As with the dendrogram, isolates expressing curli at 37uC (highlighted in yellow) were dispersed throughout the
matrix.
doi:10.1371/journal.pone.0086009.g001
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curli expression. Future study and application of this phenotype
would benefit from a higher throughput detection method.
A genetic test for the ability to produce curli fiber at physiologic
temperature would greatly facilitate testing, although it is unknown
if there is a genetic marker for 37uC curli expression. While curli
genes are conserved in E. coli, genetic factors permitting their
expression at 37uC have not been described [33]. Curli expression
is influenced by the regulator proteins CsgD and Crl [34–36], but
additional regulatory inputs are possible. A wide variety of
temperature-sensitive genes have been previously described and
may interact with this network through protein-protein interac-
tions, second messengers, or altered metabolism. Invertible genetic
elements may also influence curli expression as they do for
numerous other bacterial fibers [37]. More extensive molecular
studies of this phenotype are necessary to identify its molecular
basis.
In summary, these results suggest that 37uC curli expression
could be used to risk-stratify patients or trigger future administra-
tion of anti-virulence therapeutics [9]. The findings reported here
provide a rationale for a rapid curli-expression test that could be
used alone or in combination with other bacterial markers to assess
bacteremia risk in UTI patients, which could greatly impact
disease management and outcomes.
Supporting Information
Figure S1 Morphology and phenotypic examination of
prototypic UPEC and isogenic mutants grown on Congo
Red/Bromophenol Blue containing YESCA plates. Two
UPEC strains (UTI89 and CFT073) isogenic mutants of UTI89
(UTI89DyhjO, UTI89DcsgA, and LSR34), and a prototypic K12 E.
coli, MG1655 were grown on YESCA plates containing Congo
Red and Bromophenol Blue dyes for 48 hrs at indicated
temperatures. These strains showed different colony morphology
and color due to the differential expressions of curli (CU) and
cellulose (CE). The genotype status of curli operon (csg) and
cellulose synthetase (yhjO) is also indicated. ‘‘+’’ denotes the
presence and ‘‘2‘‘ denotes the absence of either genotype or
phenotype.
(TIFF)
Figure S2 Morphology and phenotypic determination of
UPEC grown on Congo Red/Bromophenol Blue contain-
ing YESCA plates. Bacteria were grown on YESCA plates
containing Congo Red and Bromophenol Blue dyes to assess their
ability to express curli at indicated temperatures. (A) Clinical
strains isolated from either blood (b) or urine (u) of bacteremic
patients were grown for 48 hrs at indicated temperatures. The
curli-expression status as determined by Western blotting is
indicated below each image. (B) Clinical strains isolated from the
urine of UTI patients were grown for 48 hrs at indicated
temperatures. The curli-expression status as determined by
Western blotting is indicated below each image. Results revealed
the difficulty and subjectivity of the dye-stain method in
determining curli expression status in clinical isolates.
(TIFF)
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